zepbound/tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly It’s also approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound 15 mg/0.5 mL injection
Pay in 4 interest-free payments of $5.85 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



.png)






















